Skip to main content

A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis

Completed · Phase 3 · NCT05767021

Conditions: Ulcerative Colitis, Ulcerative Colitis Chronic

At a glance

Research payments reported, 2025
$652,370
U.S. investigators named
41
Sites paid
35
Planned or actual enrollment
172

About the trial

Sponsor
Eli Lilly and Company
Tested
Mirikizumab (drug), Mirikizumab (drug)
Dates
Started 2023-05-17; completion 2026-04-27
Results posted
Yes

A study to investigate bowel urgency in adults with moderately to severely active ulcerative colitis (UC) treated with mirikizumab. The study will have 4 periods and will last for 36 weeks.

From ClinicalTrials.gov, last updated 2026-06-10. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Eli Lilly and Company reported $652,370 in research payments for this study in 2025 (45 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Gcp Clinical Research LLC $171,967
  • Sfct A Member of the Alliance Inc $74,954
  • Mgg Group Corp Inc $48,114
  • Gastroenterology Clinic of San Antonio $43,795
  • Texas Digestive Disease Consultants $24,798
  • Dr Vijayalakshmi Pratha $23,300
  • Charlotte Gastroenterology and Hepatology, PLLC $21,169
  • Gastroenterology Health PArtners PLLC $19,917
  • Care Access Research LLC $19,033
  • International Center for Research $18,892
  • Om Research LLC $15,051
  • Digestive Healthcare of Georgia $14,992
  • Noahs Ark Pediatrics $14,734
  • Research Associates of South Florida LLC $13,260
  • Gastroenterology Associates of Western $12,245
  • Asheville Gastroenterology Associates, PA $11,941
  • Tyler Research Institute LLC $10,050
  • Univ of Kansas Med Cntr Rsrch Institute $10,031
  • Clinical Research of Homestead Inc $9,000
  • Cotton Oneil Msd of Stormont Vail Healthcare $8,986
  • Indiana University $8,000
  • Henry Ford Macomb Health Center $7,321
  • Univ of South Florida Rsrch Foundation $7,250
  • Elligo Health Research Inc $7,250
  • Ny Scientific Corp $6,750
  • Houston Endoscopy and Research Center $6,723
  • Clinical Trial Network LLC $6,644
  • Delta Research PArtners LLC $5,400
  • Calin Arimie MD $4,000
  • University Gastroenterology LLC $1,690
  • Vista Health Research,llc $1,682
  • Southern Star Research Institute LLC $1,184
  • Encore Borland-Groover Clinical $1,000
  • Cleveland Clinic, OH $776
  • Linq Research, LLC $469

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.